Which 5-ASA?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Green J, Lobo A, HOLDSWORTH C, Leicester R, Gibson J, Kerr G
. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology. 1998; 114(1):15-22.
DOI: 10.1016/s0016-5085(98)70627-4.
View
2.
Kruis W, Schreiber S, Theuer D, Brandes J, Schutz E, Howaldt S
. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Gut. 2001; 49(6):783-9.
PMC: 1728533.
DOI: 10.1136/gut.49.6.783.
View
3.
Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J
. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol. 1993; 88(8):1188-97.
View
4.
Green J, Mansfield J, Gibson J, Kerr G, Thornton P
. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis. Aliment Pharmacol Ther. 2002; 16(1):61-8.
DOI: 10.1046/j.1365-2036.2002.01150.x.
View
5.
Pruitt R, Hanson J, Safdi M, Wruble L, Hardi R, Johanson J
. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis. Am J Gastroenterol. 2002; 97(12):3078-86.
DOI: 10.1111/j.1572-0241.2002.07103.x.
View